EXACT Sciences Aktie

37,20 EUR -0,69 EUR -1,81 %

09:12:25

FSE

42,26 USD -1,42 USD -3,25 %

16.04.2025

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.6,91 Mrd. EUR

Div. Rendite0,00%

WKN590273

ISINUS30063P1057

SymbolEXAS

EXACT Sciences Aktien News

Sortieren:Datum Meistgelesen

12.04.23PR NewswireExact Sciences Presents Advancements in Cancer Detection at American Association for Cancer Research® 2023 Annual Meeting

10.04.23PR NewswireExact Sciences schedules first quarter 2023 earnings call

22.02.23PR NewswireExact Sciences to participate in March investor conferences

21.02.23PR NewswireExact Sciences Announces Fourth Quarter 2022 Results

07.02.23PR NewswireExact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.

01.02.23PR NewswireExact Sciences schedules fourth quarter 2022 earnings call

08.01.23PR NewswireExact Sciences Announces Preliminary Fourth Quarter 2022 Results

03.01.23PR NewswireExact Sciences to participate in J.P. Morgan Healthcare Conference

20.12.22PR NewswireMedicare and Insurance Policy Updates in 2023 Will Improve Cancer Screening Access by Removing Patient Colonoscopy Cost Following a Positive Cologuard Test

09.12.22PR NewswireExact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients

07.12.22PR NewswireExact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS® 2022

06.12.22PR NewswireExact Sciences Highlights the Impact of Precision Oncology Portfolio on Breast Cancer Treatment with 10 New Data Presentations at SABCS® 2022

03.11.22PR NewswireExact Sciences Announces Third Quarter 2022 Results

01.11.22PR NewswireExact Sciences to participate in November investor conferences

24.10.22PR NewswireExact Sciences Expands Leadership in Colorectal Cancer Screening with New Data Presented at the American College of Gastroenterology 2022 Annual Meeting

10.10.22PR NewswireExact Sciences schedules third quarter 2022 earnings call

10.09.22PR NewswireExact Sciences Demonstrates Power of Multi-Cancer Early Detection Approach with Data Presentation at the 2022 European Society for Medical Oncology Congress

01.09.22PR NewswireExact Sciences to participate in September investor conference

03.08.22PR NewswireExact Sciences and West German Study Group Announce New Study to Validate Detection of Minimal Residual Disease in Early-Stage Breast Cancer Patients

02.08.22PR NewswireExact Sciences Announces Second Quarter 2022 Results

02.08.22PR NewswireExact Sciences and West German Study Group Announce New Study to Validate Detection of Minimal Residual Disease in Early-Stage Breast Cancer Patients

01.08.22PR NewswireExact Sciences to participate in August investor conference

08.07.22PR NewswireExact Sciences Applauds Proposed CMS Change to Colorectal Cancer Screening Policy

08.07.22PR NewswireExact Sciences schedules second quarter 2022 earnings call

21.06.22PR NewswireUltima Genomics and Exact Sciences enter long-term supply agreement aimed at improving patient access to genomic testing by driving down sequencing costs

30.05.22PR NewswireExact Sciences Showcases Breadth of Early Detection and Treatment Guidance Portfolio with Multiple Data Presentations at ASCO 2022

27.05.22PR NewswireExact Sciences Showcases Breadth of Early Detection and Treatment Guidance Portfolio with Multiple Data Presentations at ASCO 2022

27.05.22PR NewswireExact Sciences to participate in June investor conferences

02.05.22PR NewswireExact Sciences to participate in May investor conference

29.04.22PR NewswireUpdated ASCO Guidelines Strongly Recommend Use of the Oncotype DX Breast Recurrence Score® Test in Node-Negative and the Majority of Node-Positive Early-Stage Breast Cancer Patients

28.04.22PR NewswireUpdated ASCO Guidelines Strongly Recommend Use of the Oncotype DX Breast Recurrence Score® Test in Node-Negative and the Majority of Node-Positive Early-Stage Breast Cancer Patients

26.04.22PR NewswireExact Sciences Announces First Quarter 2022 Results

29.07.19ReutersDiagnostic company Exact Sciences to buy Genomic Health in $2.8 billion deal

29.07.19ReutersUPDATE 2-Diagnostic company Exact Sciences to buy Genomic Health in $2.8 bln deal

29.07.19ReutersUPDATE 1-Exact Sciences to buy Genomic Health for $2.8 billion

29.07.19ReutersExact Sciences to buy Genomic Health for $2.8 billion

28.07.19ReutersExact Sciences in advanced talks to buy Genomic Health for $2.8 billion: Bloomberg

28.07.19ReutersExact Sciences in advanced talks to buy Genomic Health for $2.8 bln- Bloomberg

EXACT Sciences News

EXACT Sciences News: auf dieser Seite finden Sie alle EXACT Sciences News und Nachrichten zur EXACT Sciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch EXACT Sciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um EXACT Sciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.